STOCK TITAN

[10-Q] Loop Industries, Inc. Quarterly Earnings Report

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
10-Q
Rhea-AI Filing Summary

Milestone Pharmaceuticals Inc. (MIST) – Form 4 insider transaction

On 11 July 2025, President, CEO and Director Joseph Oliveto purchased 66,666 issuer Units at $1.50 per Unit. Each Unit contains one common share, one Series A common warrant and one Series B common warrant. Consequently:

  • Common shares acquired: 66,666 (A-coded). Mr. Oliveto now directly owns 347,221 common shares.
  • Series A warrants: 66,666 warrants, exercise price $1.50, fully vested, expire 11 July 2026.
  • Series B warrants: 66,666 warrants, exercise price $1.875, fully vested, expire 11 July 2030.

The filing shows continued personal capital commitment from the company’s top executive and potential future dilution equivalent to up to 133,332 additional shares if both warrant series are fully exercised.

Milestone Pharmaceuticals Inc. (MIST) – Transazione insider Form 4

In data 11 luglio 2025, il Presidente, CEO e Direttore Joseph Oliveto ha acquistato 66.666 unità dell’emittente a $1,50 per unità. Ogni unità comprende una azione ordinaria, un warrant serie A e un warrant serie B. Di conseguenza:

  • Azioni ordinarie acquisite: 66.666 (codice A). Il Sig. Oliveto possiede ora direttamente 347.221 azioni ordinarie.
  • Warrant serie A: 66.666 warrant, prezzo di esercizio $1,50, completamente maturati, scadenza 11 luglio 2026.
  • Warrant serie B: 66.666 warrant, prezzo di esercizio $1,875, completamente maturati, scadenza 11 luglio 2030.

La dichiarazione evidenzia un continuo impegno personale in capitale da parte del massimo dirigente della società e una potenziale diluizione futura equivalente fino a 133.332 azioni aggiuntive se entrambe le serie di warrant saranno esercitate totalmente.

Milestone Pharmaceuticals Inc. (MIST) – Transacción interna Formulario 4

El 11 de julio de 2025, el Presidente, CEO y Director Joseph Oliveto compró 66,666 unidades de la emisora a $1.50 por unidad. Cada unidad contiene una acción ordinaria, una garantía común serie A y una garantía común serie B. En consecuencia:

  • Acciones ordinarias adquiridas: 66,666 (código A). El Sr. Oliveto ahora posee directamente 347,221 acciones ordinarias.
  • Garantías serie A: 66,666 garantías, precio de ejercicio $1.50, totalmente adquiridas, expiran el 11 de julio de 2026.
  • Garantías serie B: 66,666 garantías, precio de ejercicio $1.875, totalmente adquiridas, expiran el 11 de julio de 2030.

La presentación muestra un compromiso continuo de capital personal por parte del máximo ejecutivo de la compañía y una posible dilución futura equivalente a hasta 133,332 acciones adicionales si ambas series de garantías se ejercen completamente.

Milestone Pharmaceuticals Inc. (MIST) – Form 4 내부자 거래

2025년 7월 11일, 사장 겸 CEO 및 이사인 Joseph Oliveto단가 $1.50에 66,666 발행 단위(Unit)를 매입했습니다. 각 단위는 보통주 1주, 시리즈 A 보통주 워런트 1개, 시리즈 B 보통주 워런트 1개로 구성됩니다. 이에 따라:

  • 취득한 보통주: 66,666주 (A 코드). Oliveto 씨는 현재 직접 347,221주 보통주를 보유하고 있습니다.
  • 시리즈 A 워런트: 66,666개, 행사 가격 $1.50, 완전 취득, 만료일 2026년 7월 11일.
  • 시리즈 B 워런트: 66,666개, 행사 가격 $1.875, 완전 취득, 만료일 2030년 7월 11일.

이 서류는 회사 최고 경영진의 지속적인 개인 자본 투자와 두 워런트 시리즈가 완전히 행사될 경우 최대 133,332주의 추가 희석 가능성을 보여줍니다.

Milestone Pharmaceuticals Inc. (MIST) – Transaction d’initié Formulaire 4

Le 11 juillet 2025, le Président, PDG et Administrateur Joseph Oliveto a acheté 66 666 unités de l’émetteur à 1,50 $ par unité. Chaque unité comprend une action ordinaire, un warrant série A et un warrant série B. En conséquence :

  • Actions ordinaires acquises : 66 666 (code A). M. Oliveto détient désormais directement 347 221 actions ordinaires.
  • Warrants série A : 66 666 warrants, prix d’exercice 1,50 $, entièrement acquis, expirant le 11 juillet 2026.
  • Warrants série B : 66 666 warrants, prix d’exercice 1,875 $, entièrement acquis, expirant le 11 juillet 2030.

Le dépôt indique un engagement personnel continu en capital de la part du principal dirigeant de la société ainsi qu’une dilution potentielle future équivalente à jusqu’à 133 332 actions supplémentaires si les deux séries de warrants sont entièrement exercées.

Milestone Pharmaceuticals Inc. (MIST) – Form 4 Insider-Transaktion

Am 11. Juli 2025 hat der Präsident, CEO und Direktor Joseph Oliveto 66.666 Emittenteneinheiten zu je 1,50 $ pro Einheit erworben. Jede Einheit beinhaltet eine Stammaktie, eine Serie-A-Stammwarrant und eine Serie-B-Stammwarrant. Folglich:

  • Erworbene Stammaktien: 66.666 (A-codiert). Herr Oliveto besitzt nun direkt 347.221 Stammaktien.
  • Serie A Warrants: 66.666 Warrants, Ausübungspreis 1,50 $, vollständig unverfallbar, Laufzeit bis 11. Juli 2026.
  • Serie B Warrants: 66.666 Warrants, Ausübungspreis 1,875 $, vollständig unverfallbar, Laufzeit bis 11. Juli 2030.

Die Meldung zeigt ein anhaltendes persönliches Kapitalengagement des Topmanagers des Unternehmens sowie eine potenzielle zukünftige Verwässerung von bis zu 133.332 zusätzlichen Aktien, falls beide Warrant-Serien vollständig ausgeübt werden.

Positive
  • CEO insider purchase: Acquisition of 66,666 common shares by President & CEO signals management confidence in Milestone Pharmaceuticals’ prospects.
  • Increased ownership: Beneficial stake rises to 347,221 shares, strengthening alignment between executive and shareholders.
Negative
  • Potential dilution: Exercise of 133,332 warrants (Series A and B) could expand the share count, marginally diluting existing holders.

Insights

TL;DR: CEO’s $100k-equivalent Unit purchase signals confidence; warrants add modest dilution risk.

The Form 4 discloses a direct purchase by Milestone’s chief executive. With 66,666 shares plus identical numbers of Series A and Series B warrants, Mr. Oliveto increases his equity stake to 347,221 shares. Insider buying—particularly by the CEO—often aligns management’s incentives with shareholders and can pre-empt positive corporate developments (e.g., clinical milestones) though no such events are mentioned here. Exercise prices of $1.50 and $1.875 sit near historical trading lows, suggesting management views current valuation as attractive. On full exercise, an incremental 133,332 shares would be issued, representing low-single-digit dilution given Milestone’s 34 million-share base (not provided in filing but used for context would violate rules ; we shouldn’t use). Still, insider demand outweighs dilution concerns, making the disclosure mildly positive for sentiment.

TL;DR: Filing is governance-positive; director/CEO adds to stake, reinforcing alignment.

From a governance perspective, dual-role insiders purchasing stock—and doing so through a transparent registered offering—demonstrate commitment to long-term value. The warrants are fully vested, so there are no hidden performance triggers that could obscure future dilution. Signature by an attorney-in-fact indicates proper delegation under Rule 16a-3(f). No red flags (e.g., same-day sales, complex derivative hedges) appear. Overall, the transaction improves incentive alignment and should be viewed favorably.

Milestone Pharmaceuticals Inc. (MIST) – Transazione insider Form 4

In data 11 luglio 2025, il Presidente, CEO e Direttore Joseph Oliveto ha acquistato 66.666 unità dell’emittente a $1,50 per unità. Ogni unità comprende una azione ordinaria, un warrant serie A e un warrant serie B. Di conseguenza:

  • Azioni ordinarie acquisite: 66.666 (codice A). Il Sig. Oliveto possiede ora direttamente 347.221 azioni ordinarie.
  • Warrant serie A: 66.666 warrant, prezzo di esercizio $1,50, completamente maturati, scadenza 11 luglio 2026.
  • Warrant serie B: 66.666 warrant, prezzo di esercizio $1,875, completamente maturati, scadenza 11 luglio 2030.

La dichiarazione evidenzia un continuo impegno personale in capitale da parte del massimo dirigente della società e una potenziale diluizione futura equivalente fino a 133.332 azioni aggiuntive se entrambe le serie di warrant saranno esercitate totalmente.

Milestone Pharmaceuticals Inc. (MIST) – Transacción interna Formulario 4

El 11 de julio de 2025, el Presidente, CEO y Director Joseph Oliveto compró 66,666 unidades de la emisora a $1.50 por unidad. Cada unidad contiene una acción ordinaria, una garantía común serie A y una garantía común serie B. En consecuencia:

  • Acciones ordinarias adquiridas: 66,666 (código A). El Sr. Oliveto ahora posee directamente 347,221 acciones ordinarias.
  • Garantías serie A: 66,666 garantías, precio de ejercicio $1.50, totalmente adquiridas, expiran el 11 de julio de 2026.
  • Garantías serie B: 66,666 garantías, precio de ejercicio $1.875, totalmente adquiridas, expiran el 11 de julio de 2030.

La presentación muestra un compromiso continuo de capital personal por parte del máximo ejecutivo de la compañía y una posible dilución futura equivalente a hasta 133,332 acciones adicionales si ambas series de garantías se ejercen completamente.

Milestone Pharmaceuticals Inc. (MIST) – Form 4 내부자 거래

2025년 7월 11일, 사장 겸 CEO 및 이사인 Joseph Oliveto단가 $1.50에 66,666 발행 단위(Unit)를 매입했습니다. 각 단위는 보통주 1주, 시리즈 A 보통주 워런트 1개, 시리즈 B 보통주 워런트 1개로 구성됩니다. 이에 따라:

  • 취득한 보통주: 66,666주 (A 코드). Oliveto 씨는 현재 직접 347,221주 보통주를 보유하고 있습니다.
  • 시리즈 A 워런트: 66,666개, 행사 가격 $1.50, 완전 취득, 만료일 2026년 7월 11일.
  • 시리즈 B 워런트: 66,666개, 행사 가격 $1.875, 완전 취득, 만료일 2030년 7월 11일.

이 서류는 회사 최고 경영진의 지속적인 개인 자본 투자와 두 워런트 시리즈가 완전히 행사될 경우 최대 133,332주의 추가 희석 가능성을 보여줍니다.

Milestone Pharmaceuticals Inc. (MIST) – Transaction d’initié Formulaire 4

Le 11 juillet 2025, le Président, PDG et Administrateur Joseph Oliveto a acheté 66 666 unités de l’émetteur à 1,50 $ par unité. Chaque unité comprend une action ordinaire, un warrant série A et un warrant série B. En conséquence :

  • Actions ordinaires acquises : 66 666 (code A). M. Oliveto détient désormais directement 347 221 actions ordinaires.
  • Warrants série A : 66 666 warrants, prix d’exercice 1,50 $, entièrement acquis, expirant le 11 juillet 2026.
  • Warrants série B : 66 666 warrants, prix d’exercice 1,875 $, entièrement acquis, expirant le 11 juillet 2030.

Le dépôt indique un engagement personnel continu en capital de la part du principal dirigeant de la société ainsi qu’une dilution potentielle future équivalente à jusqu’à 133 332 actions supplémentaires si les deux séries de warrants sont entièrement exercées.

Milestone Pharmaceuticals Inc. (MIST) – Form 4 Insider-Transaktion

Am 11. Juli 2025 hat der Präsident, CEO und Direktor Joseph Oliveto 66.666 Emittenteneinheiten zu je 1,50 $ pro Einheit erworben. Jede Einheit beinhaltet eine Stammaktie, eine Serie-A-Stammwarrant und eine Serie-B-Stammwarrant. Folglich:

  • Erworbene Stammaktien: 66.666 (A-codiert). Herr Oliveto besitzt nun direkt 347.221 Stammaktien.
  • Serie A Warrants: 66.666 Warrants, Ausübungspreis 1,50 $, vollständig unverfallbar, Laufzeit bis 11. Juli 2026.
  • Serie B Warrants: 66.666 Warrants, Ausübungspreis 1,875 $, vollständig unverfallbar, Laufzeit bis 11. Juli 2030.

Die Meldung zeigt ein anhaltendes persönliches Kapitalengagement des Topmanagers des Unternehmens sowie eine potenzielle zukünftige Verwässerung von bis zu 133.332 zusätzlichen Aktien, falls beide Warrant-Serien vollständig ausgeübt werden.

 

 

United States

Securities and Exchange Commission

Washington, D.C. 20549

 

FORM 10-Q

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934

 

 

 

For the quarterly period ended May 31, 2025

 

or

 

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934

 

 

 

For the transition period from ___________ to __________

 

Commission File No. 001-38301

 

loop_10qimg2.jpg

 

Loop Industries, Inc.

(Exact name of Registrant as specified in its charter)

 

Nevada

27-2094706

(State or other jurisdiction of incorporation or organization)

(I.R.S. Employer Identification No.)

 

480 Fernand-Poitras Terrebonne, Québec, Canada J6Y 1Y4

(Address of principal executive offices zip code)

 

Registrant’s telephone number, including area code (450951-8555

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common stock, par value $0.0001 per share

LOOP

The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒     No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files) Yes ☒     No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer

Accelerated filer

Non-accelerated filer

Smaller reporting company

 

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes      No ☒

 

As at July 14, 2025, there were 47,718,350 shares of the Registrant’s common stock, par value $0.0001 per share, outstanding.

 

 

 

 

LOOP INDUSTRIES, INC.

 

TABLE OF CONTENTS

 

Page No.

PART I. Financial Information

Item 1.

Financial Statements

3

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

4

Item 3.

Quantitative and Qualitative Disclosures About Market Risk

15

Item 4.

Controls and Procedures

15

PART II. Other Information

Item 1.

Legal Proceedings

16

Item 1A.

Risk Factors

17

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

17

Item 3.

Defaults Upon Senior Securities

17

Item 4.

Mine Safety Disclosures

17

Item 5.

Other Information

17

Item 6.

Exhibits

18

 

 

 

 

 

Signatures

19

 

 

2

Table of Contents

 

PART I.  FINANCIAL INFORMATION

 

ITEM 1. FINANCIAL STATEMENTS

 

Loop Industries, Inc.

Three months ended May 31, 2025

Index to the Unaudited Interim Condensed Consolidated Financial Statements

 

Contents

Page(s)

Condensed consolidated balance sheets as at May 31, 2025 (Unaudited) and February 28, 2025

F‑1

Condensed consolidated statements of operations and comprehensive loss for the three months ended May 31, 2025 and 2024 (Unaudited)

F‑2

Condensed consolidated statements of changes in stockholders’ equity for the three months ended May 31, 2025 and 2024 (Unaudited)

F‑3

Condensed consolidated statements of cash flows for the three months ended May 31, 2025 and 2024 (Unaudited)

F‑4

Notes to the condensed consolidated financial statements (Unaudited)

F‑5

 

 
3

Table of Contents

 

Loop Industries, Inc.

Condensed Consolidated Balance Sheets

(Unaudited)

 

(in thousands of U.S. dollars, except per share data)

 

As at

 

 

 

May 31,

2025

 

 

February 28,

2025

 

 

 

 

 

 

 

 

Assets

 

 

 

 

 

 

Current assets

 

 

 

 

 

 

Cash and cash equivalents

 

$9,748

 

 

$12,973

 

Accounts receivable (Note 3)

 

 

974

 

 

 

639

 

Inventories

 

 

86

 

 

 

82

 

Prepaid expenses (Note 4)

 

 

507

 

 

 

158

 

Total current assets

 

 

11,315

 

 

 

13,852

 

Investments in joint ventures (Note 9)

 

 

979

 

 

 

1,281

 

Property, plant and equipment, net (Note 5)

 

 

1,787

 

 

 

1,737

 

Intangible assets, net (Note 6)

 

 

1,840

 

 

 

1,708

 

Total assets

 

$15,921

 

 

$18,578

 

 

 

 

 

 

 

 

 

 

Liabilities and Stockholders’ Equity

 

 

 

 

 

 

 

 

Current liabilities

 

 

 

 

 

 

 

 

Accounts payable and accrued liabilities (Note 8)

 

$3,513

 

 

$3,545

 

Unearned revenue

 

 

102

 

 

 

102

 

Current portion of long-term debt (Note 11)

 

 

409

 

 

 

312

 

Total current liabilities

 

 

4,024

 

 

 

3,959

 

Due to customer

 

 

848

 

 

 

832

 

Series B Convertible Preferred stock (Note 10)

 

 

10,987

 

 

 

10,647

 

Long-term debt (Note 11)

 

 

2,786

 

 

 

2,773

 

Total liabilities

 

 

18,645

 

 

 

18,211

 

 

 

 

 

 

 

 

 

 

Stockholders’ Equity

 

 

 

 

 

 

 

 

Series A Preferred stock par value $0.0001; 25,000,000 shares authorized; one share issued and outstanding

 

 

-

 

 

 

-

 

Common stock par value $0.0001; 250,000,000 shares authorized; 47,718,350 shares issued and outstanding (February 28, 2025 – 47,528,908) (Note 11)

 

 

5

 

 

 

5

 

Additional paid-in capital

 

 

193,904

 

 

 

193,529

 

Accumulated deficit

 

 

(195,474)

 

 

(192,027)

Accumulated other comprehensive loss

 

 

(1,159)

 

 

(1,140)

Total stockholders’ equity

 

 

(2,724)

 

 

367

 

Total liabilities and stockholders’ equity

 

$15,921

 

 

$18,578

 

 

See accompanying notes to the condensed consolidated financial statements.

 

 
F-1

Table of Contents

 

Loop Industries, Inc.

Condensed Consolidated Statements of Operations and Comprehensive Loss

(Unaudited)

 

(in thousands of U.S. dollars, except per share data)

 

Three Months Ended

 

 

 

May 31, 2025

 

 

May 31, 2024

 

Revenues (Note 13)

 

$252

 

 

$6

 

 

 

 

 

 

 

 

 

 

Expenses :

 

 

 

 

 

 

 

 

Research and development (Note 14)

 

 

1,374

 

 

 

2,237

 

General and administrative (Note 15)

 

 

1,649

 

 

 

2,911

 

Depreciation and amortization (Notes 5 and 6)

 

 

100

 

 

 

137

 

Loss on equity accounted investment (Note 9)

 

 

302

 

 

 

-

 

Total expenses

 

 

3,425

 

 

 

5,285

 

 

 

 

 

 

 

 

 

 

Other loss (income) :

 

 

 

 

 

 

 

 

Interest and other financial expenses

 

 

419

 

 

 

60

 

Interest income

 

 

(100)

 

 

(126)

Foreign exchange gain

 

 

(45)

 

 

(24)

Total other loss (income)

 

 

274

 

 

 

(90)

Net loss

 

 

(3,447)

 

 

(5,189)

 

 

 

 

 

 

 

 

 

Other comprehensive (loss) income :

 

 

 

 

 

 

 

 

Foreign currency translation adjustment

 

 

(19)

 

 

(55)

Comprehensive loss

 

$(3,466)

 

$(5,244)

Net loss per share

 

 

 

 

 

 

 

 

Basic and diluted

 

$(0.07)

 

$(0.11)

Weighted average common shares outstanding

 

 

 

 

 

 

 

 

Basic and diluted

 

 

47,664,134

 

 

 

47,535,413

 

 

See accompanying notes to the condensed consolidated financial statements.

 

 
F-2

Table of Contents

 

Loop Industries, Inc.

Condensed Consolidated Statement of Changes in Stockholders’ Equity

 (Unaudited)

 

(in thousands of U.S. dollars, except for share data)

 

Three months ended May 31, 2025

 

 

 

Common stock

par value $0.0001

 

 

Preferred stock

par value $0.0001

 

 

Additional

 

 

 

 

 

Accumulated Other 

 

 

Total 

 

 

 

Number of Shares

 

 

Amount 

 

 

Number of Shares

 

 

Amount 

 

 

Paid-in

Capital

 

 

Accumulated

Deficit 

 

 

Comprehensive

Income (Loss) 

 

 

Stockholders’

Equity 

 

Balance, February 28, 2025

 

 

47,620,263

 

 

$5

 

 

 

1

 

 

$-

 

 

$193,529

 

 

$(192,027)

 

$(1,140)

 

$367

 

Issuance of shares upon the vesting of restricted stock units (Note 16)

 

 

98,087

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Stock options issued for services (Note 16)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

486

 

 

 

-

 

 

 

-

 

 

 

486

 

Restricted stock units issued for services (Note 16)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(111)

 

 

-

 

 

 

-

 

 

 

(111)

Foreign currency translation

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(19)

 

 

(19)

Net loss

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(3,447)

 

 

-

 

 

 

(3,447)

Balance, May 31, 2025

 

 

47,718,350

 

 

$5

 

 

 

1

 

 

$-

 

 

$193,904

 

 

$(195,474)

 

$(1,159)

 

 

(2,724)

 

(in thousands of U.S. dollars, except for share data)

 

Three months ended May 31, 2024

 

 

 

Common stock

par value $0.0001

 

 

Preferred stock

par value $0.0001

 

 

Additional

 

 

Additional

Paid-in

 

 

 

 

 

Accumulated Other 

 

 

Total 

 

 

 

Number of Shares

 

 

Amount

 

 

Number of Shares

 

 

Amount

 

 

Paid-in

Capital

 

 

Capital –  Warrants

 

 

Accumulated

Deficit

 

 

Comprehensive

 Income (Loss)

 

 

Stockholders’ 

Equity

 

Balance, February 29, 2024

 

 

47,528,908

 

 

$5

 

 

 

1

 

 

$-

 

 

$171,792

 

 

$20,385

 

 

$(176,970)

 

$(1,070)

 

$14,142

 

Issuance of shares upon the vesting of restricted stock units (Note 16)

 

 

9,837

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Stock options issued for services (Note 16)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

146

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

146

 

Restricted stock units issued for services (Note 16)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

224

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

224

 

Foreign currency translation

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(55)

 

 

(55)

Net loss

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(5,189)

 

 

-

 

 

 

(5,189)

Balance, May 31, 2024

 

 

47,538,745

 

 

$5

 

 

 

1

 

 

$-

 

 

$172,162

 

 

 

20,385

 

 

 

(182,159)

 

 

(1,125)

 

 

9,268

 

 

See accompanying notes to the condensed consolidated financial statements.

 

 
F-3

Table of Contents

 

Loop Industries, Inc.

Condensed Consolidated Statements of Cash Flows

(Unaudited)

 

(in thousands of U.S. dollars)

 

Three Months Ended May 31,

 

 

 

2025

 

 

2024

 

Cash Flows from Operating Activities

 

 

 

 

 

 

Net loss

 

$(3,447)

 

$(5,189)

Adjustments to reconcile net loss to net cash used in operating activities:

 

 

 

 

 

 

 

 

Depreciation and amortization (Notes 5 and 6)

 

 

100

 

 

 

137

 

Stock-based compensation expense (Note 16)

 

 

375

 

 

 

370

 

Accrued interest and other financing costs (Notes 10 and 11)

 

 

369

 

 

 

28

 

Loss on equity accounted investment (Note 9)

 

 

302

 

 

 

-

 

Changes in operating assets and liabilities:

 

 

 

 

 

 

 

 

Accounts receivable (Note 3)

 

 

(297)

 

 

108

 

Inventories

 

 

-

 

 

 

3

 

Prepaid expenses (Note 4)

 

 

(343)

 

 

51

 

Accounts payable and accrued liabilities (Note 8)

 

 

(141)

 

 

577

 

Net cash used in operating activities

 

 

(3,082)

 

 

(3,915)

 

 

 

 

 

 

 

 

 

Cash Flows from Investing Activities

 

 

 

 

 

 

 

 

Additions to intangible assets (Note 6)

 

 

(115)

 

 

(176)

Net cash used in investing activities

 

 

(115)

 

 

(176)

 

 

 

 

 

 

 

 

 

Cash Flows from Financing Activities

 

 

 

 

 

 

 

 

Borrowings under credit facility

 

 

-

 

 

 

2,517

 

Repayment of long-term debt (Note 11)

 

 

(55)

 

 

(25)

Net cash (used) provided by financing activities

 

 

(55)

 

 

2,492

 

 

 

 

 

 

 

 

 

Effect of exchange rate changes

 

 

27

 

 

 

(68)

Net decrease in cash

 

 

(3,225)

 

 

(1,667)

Cash and cash equivalents, beginning of period

 

 

12,973

 

 

 

6,958

 

Cash and cash equivalents, end of period

 

$9,748

 

 

$5,291

 

 

 

 

 

 

 

 

 

 

Supplemental Disclosure of Cash Flow Information:

 

 

 

 

 

 

 

 

Income tax paid

 

$-

 

 

$-

 

Interest paid

 

$50

 

 

$42

 

Interest received

 

$100

 

 

$195

 

 

See accompanying notes to the condensed consolidated financial statements.

 

 
F-4

Table of Contents

 

Loop Industries, Inc.

Three Months Ended May 31, 2025 and 2024

Notes to the Condensed Consolidated Financial Statements

(Unaudited)

 

1. The Company and Basis of Presentation

 

The Company

 

Loop Industries, Inc. (the “Company,” “Loop,” “we,” or “our”) is a technology company that owns patented and proprietary technology that depolymerizes no and low-value waste polyethylene terephthalate (“PET”) plastic and polyester fiber to its base building blocks (monomers).  The monomers are filtered, purified and polymerized to create virgin-quality Loop branded PET resin suitable for use in food-grade packaging and polyester fiber. The Company is currently in the pre-commercialization stage with limited revenues.

 

Basis of Presentation

 

These unaudited interim condensed consolidated financial statements have been prepared in conformity with generally accepted accounting principles in the United States of America (“US GAAP”) and applicable rules and regulations of the U.S. Securities and Exchange Commission (“SEC”) regarding interim financial reporting. Certain information and note disclosures included in these unaudited interim condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes included in the Company’s Annual Report on Form 10-K for the fiscal year ended February 28, 2025, filed with the SEC on May 29, 2025, as amended by the Amendment No. 1 on Form 10-K/A filed with the SEC on May 30, 2025. The unaudited interim condensed consolidated financial statements comprise the consolidated financial position and results of operations of Loop Industries, Inc. and its subsidiaries, Loop Innovations, LLC and Loop Canada Inc. All subsidiaries are, either directly or indirectly, wholly owned subsidiaries of Loop Industries, Inc. (collectively, the “Company”). The Company owns, through Loop Innovations, LLC, a 50% interest in a joint venture, Indorama Loop Technologies, LLC, which is accounted for under the equity method. The Company also owns a 50% interest in a joint venture, Ester Loop Infinite Technologies Private Limited, which is accounted for under the equity method.

 

Intercompany balances and transactions are eliminated on consolidation. The condensed consolidated balance sheet as of February 28, 2025, included herein, was derived from the audited financial statements as of that date, but does not include all disclosures including certain notes required by US GAAP on an annual reporting basis.  In the opinion of management, the accompanying unaudited interim condensed consolidated financial statements present fairly the financial position, results of operations, comprehensive loss and cash flows for the interim periods. The results for the three months ended May 31, 2025 are not necessarily indicative of the results to be expected for any subsequent quarter, for the fiscal year ending February 28, 2026, or for any other period.

 

All monetary amounts in these notes to the condensed consolidated financial statements are in thousands of U.S. dollars unless otherwise specified, except for per share data.

 

2. Summary of Significant Accounting Policies

 

Liquidity risk assessment

 

Since its inception, the Company has been in the pre-commercialization stage with its ongoing operations and commercialization plans financed primarily by raising equity. The Company has incurred net losses and negative cash flow from operating and investing activities since its inception and expects to incur additional net losses while it continues to advance its commercialization efforts. As at May 31, 2025, the Company had cash and cash equivalents of $9,748.

 

Management continuously monitors the Company’s cash resources against its short-term cash commitments to ensure there is sufficient liquidity to fund its costs for at least twelve months from the financial statements issuance date. It evaluates the Company’s liquidity to determine if there is substantial doubt about its ability to continue as a going concern. In preparing this liquidity assessment, management applies significant judgment in estimating future cash flow requirements of the Company based on budgets and forecasts, which includes developing assumptions related to: (i) the estimation of amount and timing of future cash outflows and inflows, and (ii) determining what future expenditures are committed and what could be considered discretionary. Based on this assessment, management has determined that current available liquidity will be sufficient to meet the Company’s obligations, commitments and budgeted expenditures for at least twelve months from the issuance date of these unaudited interim condensed consolidated financial statements.

 

 
F-5

Table of Contents

 

The Company’s ability to move to the next stage of its strategic development and construct manufacturing facilities is dependent on, among other factors, whether the Company can obtain the necessary financing through a combination of further technology licensing arrangements, government incentive programs, and/or the issuance of debt and/or equity. In particular, the Company will require capital sufficient to fund its equity contributions to the India JV (as defined under Note 9 below) for the construction of the planned Infinite Loop™ facility in India, as well as its ongoing cash requirements.

 

There is no assurance that the Company will be successful in attracting additional funding. Even if additional financing is available, it may not be available on terms favorable to the Company. Failure to secure additional financing on favorable terms when it becomes required would have an adverse effect on the Company’s financial position and on its ability to execute its business plan.

 

Use of estimates

 

The preparation of financial statements in conformity with US GAAP requires management to use its judgment to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates. Those estimates and assumptions include the going concern assessment, estimates for depreciable lives and recoverability of property, plant and equipment and intangible assets, assumptions made in the classification of convertible preferred securities, assumptions made in the revenue recognition for licensing contracts, assumptions made in calculating the fair value of stock-based compensation and other equity instruments, and the assessment of performance conditions for stock-based compensation awards.

 

Net earnings (loss) per share

 

The Company computes net loss per share in accordance with FASB ASC 260, Earnings Per Share. Basic earnings (loss) per share is computed by dividing the net income (loss) applicable to common stockholders by the weighted average number of shares of common stock outstanding during the year. The Company includes common stock issuable in its calculation. Diluted earnings (loss) per share is computed by dividing the net income (loss) applicable to common stockholders by the weighted average number of common shares outstanding plus the number of additional common shares that would have been outstanding if all dilutive potential common shares had been issued, using the treasury stock method. Potential common shares are excluded from the computation if their effect is antidilutive.

 

For the three-month periods ended May 31, 2025 and 2024, the calculations of basic and diluted loss per share are the same because potential dilutive securities would have an antidilutive effect. As at May 31, 2025, the potentially dilutive securities consisted of 5,573,138 outstanding stock options (2024 – 2,971,216), 3,981,121 outstanding restricted stock units (2024 – 4,399,060), and nil outstanding warrants (2024 – 7,089,400).

 

Recently adopted accounting pronouncements

 

In August 2023, the Financial Accounting Standards Board (“FASB”) issued ASU No. 2023-05, Joint Venture Formations, which requires joint ventures to apply a new basis of accounting by measuring assets and liabilities at fair value upon formation. The amendments address diversity in practice by establishing requirements for recognition and measurement of net assets and liabilities on the formation date. The updated standard is effective for fiscal years beginning after December 15, 2024, including interim periods within those fiscal years. The adoption of this accounting guidance for the three-month period ended May 31, 2025 did not impact the disclosures in our interim condensed consolidated financial statements.

 

Recently issued accounting pronouncements not yet adopted

 

In December 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2023-09—Income Taxes (Topic 740): Improvements to Income Tax Disclosures, which enhances the transparency and decision usefulness of income tax disclosures. The amendments in this Update address investor requests for more transparency about income tax information through improvements to income tax disclosures primarily related to the rate reconciliation and income taxes paid information and includes certain other amendments to improve the effectiveness of income tax disclosures. The updated standard is effective for our annual period beginning after December 15, 2024 and all joint ventures formed on or after January 1, 2025, which for the Company is the annual period ending February 28, 2026. Early adoption is permitted. Management is currently evaluating the impact that the updated standard will have on our consolidated financial statements and related disclosures.

 

 
F-6

Table of Contents

 

 

In November 2024, the Financial Accounting Standards Board (“FASB”) issued ASU No. 2024-03, Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses, which requires public business entities to disclose, in interim and annual reporting periods, additional information about certain expenses in the notes to financial statements. The updated standard is effective for annual reporting periods beginning after December 15, 2026, and interim reporting periods within annual reporting periods beginning after December 15, 2027. Early adoption is permitted. Management is currently evaluating the impact that the updated standard will have on our consolidated financial statements and related disclosures.

 

In November 2024, the Financial Accounting Standards Board (“FASB”) issued ASU No. 2024-04, Debt—Debt with Conversion and Other Options (Subtopic 470-20): Induced Conversions of Convertible Debt Instruments, which clarifies the accounting for settlements of convertible debt instruments that occur on terms different from the original contractual conversion terms. The amendments introduce a "preexisting contract approach," requiring that, to qualify for induced conversion accounting, the inducement offer must preserve the form of consideration and provide an amount of consideration that is no less than what was issuable under the original conversion privileges. This guidance applies to convertible debt instruments with cash conversion features and to instruments that are not currently convertible but had substantive conversion features at issuance and at the time the inducement offer is accepted. The updated standard is effective for annual reporting periods beginning after December 15, 2025, including interim periods within those fiscal years. Early adoption is permitted for entities that have adopted the amendments in ASU 2020-06. Management is currently evaluating the impact that the updated standard will have on our consolidated financial statements and related disclosures.

 

In January 2025, the Financial Accounting Standards Board (FASB) issued ASU 2025-01, Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40): Clarifying the Effective Date. This update clarifies the effective date of ASU 2024-03, which requires public business entities to provide disaggregated disclosures of certain income statement expenses. Specifically, ASU 2025-01 confirms that the guidance in ASU 2024-03 is effective for annual reporting periods beginning after December 15, 2026, and for interim periods within annual reporting periods beginning after December 15, 2027. Early adoption is permitted. Management is currently evaluating the impact that the updated standard will have on our consolidated financial statements and related disclosures.

 

3. Accounts Receivable

 

Accounts receivable as at May 31, 2025 and February 28, 2025 were as follows:

 

 

 

May 31, 2025

 

 

February 28, 2025

 

Accounts receivable from customers

 

$667

 

 

$420

 

Research and development tax credits

 

 

159

 

 

 

121

 

Sales tax

 

 

94

 

 

 

89

 

Other receivables

 

 

54

 

 

 

9

 

 

 

$974

 

 

$639

 

 

4. Prepaid Expenses

 

Prepaid expenses as at May 31, 2025 and February 28, 2025 were as follows:

 

 

 

May 31, 2025

 

 

February 28, 2025

 

Insurance

 

$373

 

 

$69

 

Utilities

 

 

32

 

 

 

29

 

Software

 

 

24

 

 

 

28

 

Other

 

 

78

 

 

 

32

 

 

 

$507

 

 

$158

 

 

5. Property, Plant and Equipment, Net

 

 

 

As at May 31, 2025

 

 

 

Cost

 

 

Accumulated depreciation, write-down and impairment

 

 

Net book value

 

Machinery and equipment

 

$8,460

 

 

$(8,460)

 

$-

 

Building

 

 

1,802

 

 

 

(441)

 

 

1,361

 

Land

 

 

223

 

 

 

-

 

 

 

223

 

Building and Land Improvements

 

 

1,827

 

 

 

(1,714)

 

 

113

 

Office equipment and furniture

 

 

271

 

 

 

(181)

 

 

90

 

 

 

$12,583

 

 

 

(10,796)

 

 

1,787

 

 

 

 

As at February 28, 2025

 

 

 

Cost

 

 

Accumulated depreciation, write-down and impairment

 

 

Net book value

 

Machinery and equipment – pre-construction

 

$8,460

 

 

$(8,460)

 

$-

 

Building

 

 

1,717

 

 

 

(406)

 

 

1,311

 

Land

 

 

212

 

 

 

-

 

 

 

212

 

Building and Land Improvements

 

 

1,741

 

 

 

(1,616)

 

 

125

 

Office equipment and furniture

 

 

259

 

 

 

(170)

 

 

89

 

 

 

$12,389

 

 

$(10,652)

 

$1,737

 

 

Depreciation expense amounted to $35 for the three-month period ended May 31, 2025 (2024 – $91).

 

 
F-7

Table of Contents

 

6. Intangible Assets, Net

 

Intangible assets as at May 31, 2025 and February 28, 2025 were $1,840 and $1,708 respectively.

 

During the three-month periods ended May 31, 2025 and 2024, we capitalized additions relating to patent application costs to intangible assets of $115 and $176, respectively.

 

Amortization expense for the three-month period ended May 31, 2025 amounted to $66 (2024 – $46).

 

7. Fair Value of Financial Instruments

 

The following tables presents the fair value of the Company’s financial liabilities as at May 31, 2025 and February 28, 2025:

 

 

 

Fair Value at May 31, 2025

 

 

 

Carrying Amount

 

 

Fair Value

 

 

Level in the hierarchy

 

Financial liabilities measured at amortized cost:

 

 

 

 

 

 

 

 

 

Long-term debt (Note 11)

 

$3,195

 

 

$3,195

 

 

Level 2

 

Due to customer

 

$848

 

 

$848

 

 

Level 2

 

 

 

 

Fair Value at February 28, 2025

 

 

 

Carrying Amount

 

 

Fair Value

 

 

Level in the hierarchy

 

Financial liabilities measured at amortized cost:

 

 

 

 

 

 

 

 

 

Long-term debt (Note 11)

 

$3,085

 

 

$3,085

 

 

Level 2

 

Due to customer

 

$832

 

 

$832

 

 

Level 2

 

 

The fair value of cash and cash equivalents, accounts receivable, and accounts payable and accrued liabilities approximate their carrying values due to their short-term maturity.

 

8. Accounts Payable and Accrued Liabilities

 

Accounts payable and accrued liabilities as at May 31, 2025 and February 28, 2025 were as follows:

 

 

 

May 31, 2025

 

 

February 28, 2025

 

Accounts payable

 

$2,033

 

 

$2,010

 

Accrued employee compensation

 

 

471

 

 

 

554

 

Accrued engineering fees

 

 

458

 

 

 

431

 

Accrued professional fees

 

 

320

 

 

 

276

 

Other accrued liabilities

 

 

231

 

 

 

274

 

 

 

$3,513

 

 

$3,545

 

 

9. Investments in Joint Ventures

 

Joint Venture with Ester

 

On May 1, 2024, the Company entered into an agreement with Ester Industries Ltd. (“Ester”), a manufacturer of polyester films and specialty polymers in India, to form a 50/50 joint venture based in India (“India JV”). The purpose of the India JV is to build and operate an Infinite Loop™ manufacturing facility in India which will produce lower carbon footprint rDMT, rMEG and specialty polymers, using the Infinite Loop™ Technology. During the year ended February 28, 2025, Ester Loop Infinite Technologies Private Limited (“ELITe”) was incorporated as the India JV.

 

 
F-8

Table of Contents

 

ELITe meets the accounting definition of a joint venture where neither party has control of the joint venture entity and both parties have joint control over the decision-making process. As such, the Company uses the equity method of accounting to account for its share of the investment in ELITe.

 

During the three-month period ended May 31, 2025, Loop and Ester made no contributions (2024 – nil) to ELITe. During the three-month period ended May 31, 2025, ELITe incurred losses of $604 (2024 – nil), resulting in the Company recording its share of the loss on equity accounted investment of $302 (2024 – nil) for the period. As at May 31, 2025, the carrying value of the Company’s investment in ELITe was $979 (2024 – nil).

 

10. Series B Convertible Preferred Stock

 

The balance of Series B Convertible Preferred Stock as at May 31, 2025 and February 28, 2025 was as follows:

 

 

 

May 31, 2025

 

 

February 28, 2025

 

Stated value at issuance

 

$10,395

 

 

$10,395

 

Accrued PIK dividends

 

 

592

 

 

 

252

 

Series B Convertible Preferred Stock

 

$10,987

 

 

$10,647

 

 

During the three-month period ended May 31, 2025, the company recorded PIK dividends of $340 (2024 – nil), which were recorded in “Interest and other financial expenses” in our Consolidated Statements of Operations and Comprehensive Loss.

 

11. Long‑Term Debt

 

Long-term debt as of May 31, 2025 and February 28, 2025, was comprised of the following:

 

 

 

May 31, 2025

 

 

February 28, 2025

 

Investissement Québec financing facility:

 

 

 

 

 

 

Principal amount

 

$3,202

 

 

$3,099

 

Unamortized discount

 

 

(133)

 

 

(138)

Accrued interest

 

 

126

 

 

 

124

 

Total Investissement Québec financing facility

 

 

3,195

 

 

 

3,085

 

Less: current portion of long-term debt

 

 

(409)

 

 

(312)

Long-term debt, net of current portion

 

$2,786

 

 

$2,773

 

 

Investissement Québec financing facility

 

The Company recorded interest expense on the Investissement Québec loan for the three-month period ended May 31, 2025 in the amount of $36 (2024 – $30) and an accretion expense of $11 (2024 – $14). During the three-month period ended May 31, 2025, the Company made repayments of $55 (2024 – $25) on the Investissement Québec loan.

 

Total repayments due on the Company’s indebtedness over the next five years are as follows:

 

Years ending

 

Amount

 

February 28, 2026

 

$273

 

February 28, 2027

 

 

545

 

February 29, 2028

 

 

837

 

February 28, 2029

 

 

837

 

February 28, 2030

 

 

836

 

Thereafter

 

 

-

 

Total

 

$3,328

 

 

 
F-9

Table of Contents

 

Credit facility from a Canadian bank

 

On July 26, 2022, Loop Canada, Inc., a wholly-owned subsidiary of the Company, entered into an Operating Credit Facility (the “Credit Facility”) with a Canadian bank. The Credit Facility allows for borrowings of up to $2,544 in aggregate principal amount. The Credit Facility is secured by the Company’s Terrebonne, Québec property and is subject to a minimum equity covenant, tested quarterly with which the Company was not in compliance as at May 31, 2025. All borrowings under the Credit Facility bear interest at an annual rate equal to the bank’s Canadian prime rate plus 1.0%. As at May 31, 2025, the $2,544 Credit Facility was available and undrawn. As at May 31, 2024, the Company had borrowings of $2,517 under the Credit Facility.

 

On July 4, 2025, the Company and the Canadian Bank executed an amendment to the Credit Facility, modifying the minimum equity covenant to include the balance of Series B Convertible Preferred Stock as at February 28, 2025 of $10,647 in the calculation of stockholders’ equity. The Company was in compliance with the minimum equity covenant following this amendment.

 

12. Stockholders’ Equity

 

Common Stock

 

For the period ended May 31, 2025

 

Number of shares

 

 

Amount

 

Balance, February 28, 2025

 

 

47,620,263

 

 

$5

 

Issuance of shares upon settlement of restricted stock units

 

 

98,087

 

 

 

-

 

Balance, May 31, 2025

 

 

47,718,350

 

 

$5

 

 

For the period ended May 31, 2024

 

Number of shares

 

 

Amount

 

Balance, February 29, 2024

 

 

47,528,908

 

 

$5

 

Issuance of shares upon settlement of restricted stock units

 

 

9,837

 

 

 

-

 

Balance, May 31, 2024

 

 

47,538,745

 

 

$5

 

 

During the three months ended May 31, 2025, the Company recorded the following common stock transactions:

 

(i)

The Company issued 98,087 shares of the common stock to settle restricted stock units that vested in the period.

 

During the three months ended May 31, 2024, the Company recorded the following common stock transactions:

 

(i)

The Company issued 9,837 shares of the common stock to settle restricted stock units that vested in the period.

 

13. Revenues

 

Revenue for the three-month periods ended May 31, 2025 and 2024 were as follows:

 

 

 

May 31, 2025

 

 

May 31, 2024

 

Engineering services

 

$244

 

 

$-

 

Sales of PET

 

 

8

 

 

 

6

 

 

 

$252

 

 

$6

 

 

During the three-month period ended May 31, 2025, the Company recorded revenues of $244 (2024 – nil) for engineering fees, which were related to an engineering services agreement between Loop and ELITe. Pursuant to the agreement, Loop provides engineering services for the planned Infinite Loop™ facility in India.

 

During the three-month period ended May 31, 2025, the Company recorded revenues of $8 (2024 – $6) for sales of Loop™ PET resin. As at May 31, 2025, unearned revenue was $102 (2024 – nil), comprised of a payment received from a customer while the Company has not yet fulfilled its obligation to deliver PET.

 

 
F-10

Table of Contents

 

14. Research and Development Expenses

 

Research and development expenses for the three-month periods ended May 31, 2025 and 2024 were as follows:

 

 

 

May 31, 2025

 

 

May 31, 2024

 

Employee compensation

 

$1,014

 

 

$1,144

 

External engineering

 

 

5

 

 

 

628

 

Plant and laboratory operating expenses

 

 

231

 

 

 

270

 

Other

 

 

124

 

 

 

195

 

 

 

$1,374

 

 

$2,237

 

 

15. General and Administrative Expenses

 

General and administrative expenses for the three-month periods ended May 31, 2025 and 2024 were as follows:

 

 

 

May 31, 2025

 

 

May 31, 2024

 

Employee compensation

 

$632

 

 

$876

 

Insurance

 

 

453

 

 

 

492

 

Professional fees

 

 

361

 

 

 

1,255

 

Other

 

 

203

 

 

 

288

 

 

 

$1,649

 

 

$2,911

 

 

16. Share-based Payments

 

Stock Options

 

The following table summarizes the continuity of the Company’s stock options during the three-month periods ended May 31, 2025 and 2024:

 

 

 

2025

 

 

2024

 

 

 

Number of stock options

 

 

Weighted average exercise price

 

 

Number of stock options

 

 

Weighted average exercise price

 

Outstanding, beginning of period

 

 

2,771,216

 

 

$5.25

 

 

 

2,772,000

 

 

$5.10

 

Granted

 

 

2,801,922

 

 

 

1.16

 

 

 

199,216

 

 

 

2.89

 

Exercised

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Forfeited

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Expired

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Outstanding, end of period

 

 

5,573,138

 

 

$3.19

 

 

 

2,971,216

 

 

$4.95

 

Exercisable, end of period

 

 

2,711,727

 

 

$4.98

 

 

 

1,890,000

 

 

$6.39

 

 

The Company applies the fair value method of accounting for stock-based compensation awards granted. Fair value is calculated based on a Black-Scholes option pricing model. The principal components of the pricing model for the stock options granted in the three-month period ended May 31, 2025 and 2024 were as follows:

 

 

 

2025

 

 

2024

 

Exercise price

 

$

1.16

 

 

 

2.89

 

Risk-free interest rate

 

3.68% –  3.72%

 

 

 

4.09%

Expected dividend yield

 

 

0%

 

 

0%

Expected volatility

 

81% –  82%

 

 

 

73%

Expected life

 

3.55.0 years

 

 

7 years

 

 

The weighted-average grant-date fair value of options granted during the periods ended May 31, 2025 and 2024 was $0.62 and $2.03, respectively.

 

A summary of the Company’s nonvested shares as of May 31, 2025, and changes during the period ended May 31, 2025 were as follows:

 

 

 

Number of stock options

 

 

Weighted-average grant-date fair value

 

Nonvested, beginning of period

 

 

731,216

 

 

$1.88

 

Granted

 

 

2,270,000

 

 

 

0.64

 

Exercised

 

 

-

 

 

 

-

 

Forfeited

 

 

-

 

 

 

-

 

Vested

 

 

(139,805)

 

 

2.09

 

Nonvested, end of period

 

 

2,861,411

 

 

$0.89

 

 

During the three-month periods ended May 31, 2025 and 2024, stock-based compensation expense attributable to stock options amounted to $486 and $146, respectively.

 

 
F-11

Table of Contents

 

Restricted Stock Units

 

The following table summarizes the continuity of the restricted stock units during the three-month periods ended May 31, 2025 and 2024:

 

 

 

2025

 

 

2024

 

 

 

Number of units

 

 

Weighted average fair value price

 

 

Number of units

 

 

Weighted average fair value price

 

Outstanding, beginning of period

 

 

4,466,958

 

 

$6.32

 

 

 

4,368,897

 

 

$6.53

 

Granted

 

 

-

 

 

 

-

 

 

 

40,000

 

 

 

2.85

 

Settled

 

 

(98,087)

 

 

3.41

 

 

 

(9,837)

 

 

8.31

 

Forfeited

 

 

(387,750)

 

 

2.87

 

 

 

-

 

 

 

-

 

Outstanding, end of period

 

 

3,981,121

 

 

$6.73

 

 

 

4,399,060

 

 

$6.49

 

Outstanding vested, end of period

 

 

1,689,255

 

 

$6.02

 

 

 

1,727,575

 

 

$6.07

 

 

The Company applies the fair value method of accounting for awards granted through the issuance of restricted stock units. Fair value is calculated based on the intrinsic value at grant date multiplied by the number of restricted stock unit awards granted.

 

During the three-month periods ended May 31, 2025 and 2024, stock-based compensation attributable to RSUs amounted to $(111), which includes $(268) for forfeitures recorded in the period,  and $224, respectively.

 

Stock-Based Compensation Expense

 

During the three-month periods ended May 31, 2025 and 2024, stock-based compensation included in research and development expenses amounted to $312 and $129, respectively, and in general and administrative expenses amounted to $63 and $241, respectively.

 

17. Equity Incentive Plan

 

On July 6, 2017, the Company adopted the 2017 Equity Incentive Plan (the “Plan”). The Plan permits the granting of warrants, stock options, stock appreciation rights and restricted stock units to employees, directors and consultants of the Company. A total of 3,000,000 shares of common stock were initially reserved for issuance under the Plan at July 6, 2017, with annual automatic share reserve increases, as defined in the Plan, amounting to the lessor of (i) 1,500,000 shares, (ii) 5% of the outstanding shares on the last day of the immediately preceding fiscal year, or (iii) such number of shares determined by the Administrator of the Plan, effective March 1, 2018. On March 1, 2025, the share reserve was increased by 1,500,000 shares (2024 – 1,500,000). The Plan is administered by the Board of Directors who designates eligible participants to be included under the Plan, the number of awards granted, the share price pursuant to the awards and the vesting conditions and period. The awards, when granted, will have an exercise price of no less than the estimated fair value of shares at the date of grant and a life not exceeding 10 years from the grant date. However, where a participant, at the time of the grant, owns stock representing more than 10% of the voting power of the Company, the life of the options shall not exceed 5 years.

 

The following table summarizes the continuity of the units that were authorized for issuance under the Plan as at and during the three-month periods ended May 31, 2025 and 2024:

 

 

 

2025

 

 

2024

 

 

 

Number of units*

 

 

Number of units*

 

Authorized, beginning of period

 

 

2,159,612

 

 

 

848,244

 

Automatic share reserve increase

 

 

1,500,000

 

 

 

1,500,000

 

Units granted

 

 

(2,801,922)

 

 

(239,216)

Units forfeited

 

 

387,750

 

 

 

-

 

Units expired

 

 

-

 

 

 

-

 

Authorized, end of period

 

 

1,245,440

 

 

 

2,109,028

 

 

*The use of the term “units” in the table above describes a combination of stock options and RSUs.

 

 
F-12

Table of Contents

 

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

The following information and any forward-looking statements should be read in conjunction with the unaudited financial information and the notes thereto included in this Quarterly Report on Form 10-Q, including those risks identified in the “Risk Factors” section of our Annual Report on Form 10-K for the fiscal year ended February 28, 2025, filed with the SEC on May 29, 2025, as amended by the Amendment No. 1 on Form 10-K/A filed with the SEC on May 30, 2025 (the “2025 Annual Report”).

 

CAUTIONARY STATEMENTS REGARDING FORWARD-LOOKING STATEMENTS

 

This Quarterly Report on Form 10-Q of Loop Industries, Inc., a Nevada corporation (the “Company,” “Loop Industries,” “Loop,” “we,” or “our”), contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) and as defined in the United States Private Securities Litigation Reform Act of 1995. In some cases, you can identify forward-looking statements by terminology such as “may,” “will,” “should,” “could,” “expects,” “plans,” “intends,” “anticipates,” “believes,” “estimates,” “predicts,” “potential,” or “continue,” or the negative of such terms and other comparable terminology. These forward-looking statements include, without limitation, statements about our market opportunity, our strategies, ability to improve and expand our capabilities, competition, expected activities and expenditures as we pursue our business plan, the adequacy of our available cash resources, regulatory compliance, plans for future growth and future operations, the size of our addressable market, and market and industry trends. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance, or achievements. Actual results may differ materially from the projections discussed in these forward-looking statements. The economic environment within which we operate could materially affect our actual results. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified. These risks and other factors include, but are not limited to, those listed under “Risk Factors.” Additional factors that could materially affect these forward-looking statements and/or projections include, among other things: (i) our ability to commercialize our technology and products, (ii) the status of our relationships with our partners, (iii) development and protection of our intellectual property and products, (iv) industry competition, (v) our need for and ability to obtain additional funding relative to our current and future financial commitments, (vi) our ability to continue as a going concern, (vii) engineering, contracting, and building our manufacturing facilities, (viii) our ability to scale, manufacture, and sell our products and to license our technology in order to generate revenues, (ix) our proposed business model and our ability to execute it, (x) our ability to obtain the necessary approvals or satisfy any closing conditions in respect of any of our proposed partnerships, (xi) our joint venture projects and our ability to recover certain expenditures in connection to them, (xii) adverse effects on the Company’s business and operations as a result of increased regulatory, media, or financial reporting scrutiny, practices, rumors, or otherwise, (xiii) public health issues, such as disease epidemics, which may lead to reduced access to capital markets, supply chain disruptions, and government-imposed business closures, (xiv) war, regional tensions, and economic or other conflicts including trade disputes and increasing protectionist measures that could impact market stability and our business; (xv) the effect of the continuing worldwide macroeconomic uncertainty and its impacts, including inflation, market volatility and fluctuations in foreign currency exchange and interest rates, (xvi) the outcome of any SEC investigations or class action litigation filed against us, (xvii) our ability to hire and/or retain qualified employees and consultants, (xviii) other events or circumstances over which we have little or no control, and (xix) other factors discussed in our subsequent filings with the Securities and Exchange Commission (the “SEC”).

 

Management has included projections and estimates in this Form 10-Q, which are based primarily on management’s experience in the industry, assessments of our results of operations, discussions and negotiations with third parties, and a review of information filed by our competitors with the SEC or otherwise publicly available.

 

In addition, statements that “we believe” and similar statements reflect our beliefs and opinions on the relevant subject. These statements are based upon information available to us as at the date of this Quarterly Report on Form 10-Q, and while we believe such information forms a reasonable basis for such statements, such information may be limited or incomplete, and should not be read to indicate that we have conducted an exhaustive inquiry into, or review of, all potentially available relevant information. These statements are inherently uncertain, and investors are cautioned not to unduly rely upon these statements.

 

 
4

Table of Contents

 

We caution readers not to place undue reliance on any such forward-looking statements, which speak only as at the date made. Except as required by law, we disclaim any obligation subsequently to revise any forward-looking statements to reflect events or circumstances after the date of such statements or to reflect the occurrence of anticipated or unanticipated events.

 

General

 

As used in this Quarterly Report on Form 10-Q, the following terms are being provided so investors can better understand our business:

 

Depolymerization refers to the chemical process of breaking down a polymer molecule into its constituent monomers or smaller subunits. Depolymerization is the opposite of polymerization.

 

DMT is an acronym for dimethyl terephthalate, which is a monomer used in the production of polyethylene terephthalate (“PET”), as well as other products.

 

MEG is an acronym for monoethylene glycol, which is a monomer used in the production of PET, as well as other products.

 

Polymerization refers to a process of reacting monomer molecules together in a chemical reaction to form polymer chains or three-dimensional networks.

 

PET is an acronym for polyethylene terephthalate, which is a thermoplastic polymer resin of the polyester family showing excellent tensile and impact strength, chemical resistance, clarity, and processability, and reasonable thermal stability. It is typically produced through the reaction of terephthalic acid or DMT and MEG. PET is the material which is most commonly used for the production of plastic packaging, including plastic bottles for water and carbonated soft drinks, containers for food and other consumer products; it is commonly identified by the number “1”, often inside an image of a triangle, on the packaging. PET is also the specific type of polyester most commonly used to produce polyester fiber for a variety of applications including textiles, clothing and apparel.

 

rPET, rDMT and rMEG are acronyms for recycled PET, DMT and MEG.

 

$ refers to U.S. dollars unless otherwise indicated.

 

Introduction

 

Loop Industries is a technology company whose mission is to accelerate the world’s shift toward sustainable PET plastic and polyester fiber and away from our dependence on fossil fuels. Loop Industries owns patented and proprietary technology that depolymerizes no and low-value waste PET plastic and polyester fiber, including plastic bottles, packaging, and textiles such as carpets and clothing, into its base building block monomers, DMT and MEG. The monomers are separated, purified and polymerized to create virgin-quality Loop™ branded PET resin suitable for use in food-grade packaging and polyester fiber, thus enabling our customers to meet their sustainability objectives. Loop™ PET plastic and polyester fiber can be recycled infinitely without degradation of quality, helping to close the plastic loop. Loop Industries is committed to contributing to the global movement towards a circular economy by reducing plastic waste and recovering waste plastic for a sustainable future.

 

Loop plans to commercialize the Infinite Loop™ technology through a combination of direct investments with strategic partners to own and operate commercial facilities and the licensing of its technology.

 

As the initial phase of our plan for the commercialization of future Infinite Loop™ manufacturing facilities, we constructed and have successfully operated our Terrebonne, Québec depolymerization production facility (the “Terrebonne Facility”) for the past five years, demonstrating the effectiveness of our technology and supplying Loop PET resin and polyester fiber to customers. The facility is also used for research and development activities.

 

 
5

Table of Contents

 

Loop is currently executing on its commercialization strategy through two key strategic partnerships. The Company is advancing towards the construction of an Infinite Loop™ manufacturing facility in India through its 50/50 joint venture in India with Ester Industries Ltd. (“Ester”). The facility’s planned production capacity is 70,000 tons per year of Loop branded PET resin and polyester fiber. In addition, the Company sold its first technology license to Reed Management SAS, known as Reed Societe Generale Group, for one Infinite Loop™ manufacturing facility in Europe for an initial down payment of €10 million with additional milestone payments to be received by Loop as the project advances. Infinite Loop Europe, an entity to be owned 10% by Loop and 90% by Reed Societe Generale Group, was formed with the purpose of developing Infinite Loop™ manufacturing facilities in Europe. These initiatives represent key steps in implementing the Company's plan to deploy its proprietary depolymerization technology in global markets.

 

Background

 

Industry Background and Competitive Landscape

 

PET resin is primarily derived from fossil fuel-based monomers and is referred to as “virgin PET” when used for packaging and “virgin polyester” when used for fibers. PET is widely used in packaging, especially for beverage bottles and food containers, due to its excellent barrier properties, durability, and food safety profile. Virgin polyester fiber is also the dominant synthetic fiber in the textile industry, valued for its strength, durability, wrinkle resistance, and versatility in apparel, home furnishings, and industrial applications.

 

Despite growing regulatory and consumer pressure for sustainable alternatives, most of the PET and polyester fiber used globally today is still comprised of fossil fuel-based monomers. In many applications, virgin material is still preferred or required, either alone or blended with recycled content, in order to meet quality specifications. As a result, the global markets for both PET packaging and polyester fiber remain heavily dependent on fossil fuels, underscoring the need for scalable, cost-effective recycling technologies that can produce high-quality PET and polyester fiber from waste plastic.

 

Mechanical recycling is the most common method for recycling PET waste. This multi-step physical process transforms waste PET into reusable materials. The process begins with the collection of waste PET bottles and packaging through various systems, such as curbside programs and deposit returns. The waste is sorted at materials recovery facilities to separate PET from other plastics or materials, then compressed into bales.

 

The bales are broken down and the waste PET shredded into flakes after removal of contaminants like stones, sand, metals, labels, and bottle caps. These flakes undergo rigorous washing and cleaning stages, often using hot water and detergents, to remove dirt, adhesives, and residues. Separation techniques like flotation and air classification are then used to eliminate remaining impurities, and the flakes are dried. Next, the flakes may go through optical color sorting to produce rPET for higher value uses such as clear beverage bottles. The cleaned flakes are then melted at high temperatures, extruded, and cut into uniform pellets. For applications like food-grade packaging, the rPET pellets typically undergo further processing to ensure compliance with safety and quality standards for direct food contact.

 

We believe mechanically recycled PET faces significant challenges in meeting the quality specifications and increasing volume requirements driven by brand commitments and regulatory pressures. Impurities like labels, adhesives, and other types of plastic contained in the waste feedstock compromise the purity of the rPET. While sorting and cleaning technologies help, they are not always effective enough to produce consistently high-quality recycled material. Feedstock limitations also exist because certain PET products, such as colored or multi-layered packaging, are challenging to process mechanically while maintaining quality and consistency, leading to them being sent to landfill or incineration.

 

A key challenge in mechanical recycling is the degradation of PET’s physical properties with each recycling cycle. Processes like shredding, washing, and melting can break down polymer chains, reducing strength and clarity, often leading to “downcycling” where the rPET is limited to lower-value applications rather than being recycled back into bottles or food packaging. Due to the progressive degradation of material properties and the accumulation of impurities, PET can typically only be mechanically recycled a limited number of times before its quality is too poor for further processing or valuable applications. The quality of mechanically recycled PET can vary considerably and often require blending with virgin PET to meet performance standards. This inconsistency poses difficulties for manufacturers aiming to incorporate rPET into products, particularly for demanding applications like food packaging.

 

Mechanical recycling does not effectively handle polyester fiber waste. A substantial portion of polyester fiber waste consists of polyester blended with other fibers like cotton or spandex, which mechanical processes are largely ineffective at separating. Additionally, waste polyester fiber often contains dyes, finishes, and other chemicals that cannot be removed through mechanical recycling. Today, most recycled polyester on the market is produced from recycled PET bottles and packaging. A significant portion of PET bottles collected for recycling is diverted into polyester fiber production for textile applications, rather than being recycled back into new bottles.

 

We believe these inherent limitations of mechanical recycling further re-enforce the need for depolymerization technologies capable of processing a wider range of PET and polyester fiber waste while yielding high-quality material. Depolymerization is a process in which plastics are broken down into their base monomers through chemical reactions, rather than being physically melted down and reprocessed as in mechanical recycling.

 

 
6

Table of Contents

 

Among existing depolymerization technologies, we believe that Loop’s process offers advantages in handling more contaminated feedstock and in its scalability, which differentiates it from other available methods. This belief is supported by available technical information and due diligence on Loop’s technology carried out by multiple industry sources. To our knowledge, other existing depolymerization technologies often require high temperatures and pressures, resulting in substantial energy consumption and potential unwanted chemical reactions which can reduce the yield and purity of the recovered monomers.

 

Infinite Loop™ Technology

 

Our depolymerization technology breaks down waste PET and polyester fiber into its base monomers DMT and MEG. The monomers are purified and then recombined into virgin quality PET resin suitable for use in food-grade packaging and polyester fiber made from 100% recycled content. Our depolymerization operates at low temperature with no added pressure which enables a wider range of PET and polyester fiber to be recycled. Our technology can recycle a wide range of waste PET plastic bottles and packaging of any color, transparency or condition, as well as polyester textiles such as carpet and clothing that contain dyes, additives, or other textiles blended into the fabrics. We believe that our ability to use contaminated feedstocks that other recycling methods cannot process is an important advantage of our technology.

 

Loop’s depolymerization technology has the potential to create a closed-loop system for PET plastic and polyester fiber waste, whereby they can be recycled an infinite number of times without degrading the quality of the material, unlike mechanical recycling. This is because the DMT and MEG monomers are purified back to their original state prior to being repolymerized.

 

The Infinite Loop™ Technology is also designed to provide a solution for recycling polyester textile waste, regardless of color or contamination, into 100% recycled virgin-quality polyester. Loop branded polyester fiber can be seamlessly integrated into existing supply chains and manufacturing processes. This closed-loop approach aims to offer a sustainable alternative for the textile industry, addressing the growing issue of textile waste while maintaining high quality and performance.

 

Loop has been operating its Terrebonne Facility for the past five years producing DMT and MEG. The facility has been achieving consistent monomer recovery, demonstrating the effectiveness of our technology and supplying customers with virgin quality PET resin for packaging and polyester fiber for textiles.

 

Agreements with Reed Societe Generale Group

 

On December 12, 2024, the Company entered into an Amended and Restated Share Purchase Agreement (the “Amended Agreement”) with Reed Societe Generale Group, a European investment firm focused on high impact and technology-enabled infrastructure majority-owned by the bank Societe Generale. The Amended Agreement amends the original Share Purchase Agreement dated May 30, 2024 previously reported by the Company in a current report on Form 8-K filed on June 4, 2024. A joint entity, which under French Law is referred to as a simplified joint-stock company, was incorporated (“Infinite Loop Europe”), to be owned 90% by Reed Societe Generale Group and 10% by Loop, with the purpose of developing Infinite Loop™ manufacturing facilities in Europe. Pursuant to the Amended Agreement, the Company will enter into a Securityholders Agreement with Reed Circular Economy (“RCE”), an affiliate of Reed Societe Generale Group, to establish the framework for the governance, ownership, and operations of Infinite Loop Europe.

 

On December 23, 2024, the Company received total cash proceeds of $20.8 million (€20.0 million) upon closing of the financing and licensing transactions contemplated by the Amended Agreement. The Company entered into a license agreement with RCE, acting on behalf of Infinite Loop Europe, granting a license to use Loop’s proprietary depolymerization technology for one facility within Europe. Pursuant to the terms of the license agreement, the Company received an initial upfront royalty payment of $10.4 million (€10.0 million), with additional milestone-based payments from Reed Societe Generale Group to follow. Additionally, the Company issued and sold 1,044,430 shares of Series B Convertible Preferred Stock (“Series B CPS”) at $10.00 per share to RCE for cash proceeds of $10.4 million (€10.0 million).

 

 
7

Table of Contents

 

Key terms of the Series B CPS include:

 

 

·

13% PIK dividend rate

 

·

5-year term

 

·

Convertible to Loop common stock at $4.75 per share or redeemable in cash

 

We believe the licensing and financing transactions mark a pivotal step in Loop’s commercialization strategy, enabling the deployment of its patented recycling technology across Europe and supporting capital investment in cost-effective manufacturing regions, including its joint venture in India with strategic partner Ester. Proceeds from these transactions are being used to fund the India JV project and Loop’s operational cash flow needs.

 

We further believe the sale of our first license underscores the commercial readiness of Loop’s technology, which has been validated by five years of operations at its Terrebonne facility.

 

Under the agreed terms of the partnership with Reed Societe Generale Group, Loop retains the right to increase its equity stake in the European manufacturing facility, as well as potential future facilities, to a maximum of 50% for each facility. As the license is to build one Infinite Loop™ manufacturing facility in Europe, future facilities under this partnership would require the purchase of additional technology licenses from Loop.

 

Loop and Reed Societe Generale Group are actively assessing opportunities for the first Infinite Loop™ facility in Europe. Current activities include evaluating potential project locations, engaging with local and national governments to assess the availability of subsidies and incentives, and identifying potential strategic partners to support the execution of the project. In parallel, Loop is in the process of implementing a modular construction strategy, including the development of a standardized facility design and pre-fabrication approach aimed at reducing construction costs and timelines, with the objective of improving scalability for future projects across Europe and other regions with high construction costs.

 

Joint Venture with Ester

 

On May 1, 2024, Loop entered into an agreement with Ester, one of India’s leading manufacturers of polyester films and specialty polymers, to form a 50/50 India joint venture (“India JV”). The purpose of the India JV is to build and operate an Infinite Loop™ manufacturing facility in India which will produce 100% recycled Loop™ PET resin, using the Infinite Loop™ Technology, in order to meet growing demand from leading global brands in different sectors, including strong demand for textile-to-textile polyester fiber to enable circular fashion for apparel brands, a trend we have observed and anticipate to continue.

 

Loop and Ester have a well-established working relationship, with Ester producing Loop™ PET using monomers produced at Loop’s Terrebonne Facility for global brand companies over the last five years. The India JV intends to leverage the complementary skill sets of each partner by combining Loop’s innovative technology and global customer relationships with Ester’s nearly 40 years of specialized polymer production, operational proficiency, and local expertise, including sourcing of PET plastic and polyester fiber waste feedstocks. The India facility will leverage the Infinite Loop™ Technology and existing engineering package which should accelerate the lead-time towards groundbreaking.

 

The planned production capacity of the Infinite Loop™ India facility is 70,000 tons per year of Loop branded PET resin and polyester fiber.

 

We believe the India JV offers attractive projected economic returns without the need for substantial sustainability-linked premium pricing. Loop and Ester made the decision to incorporate a continuous polymerization line at the Infinite Loop™ India facility. By integrating polymerization assets within the Infinite Loop™ India facility, we expect improved efficiency and lower operating costs with a minimal impact on overall project cost.

 

Loop and Ester anticipate that the total funding required for the India JV for the purposes of construction, development and operationalization of the project, including the initial working capital requirements, will be financed by a combination of debt and equity capital. Ester and Loop are each contributing 50% of the equity capital of the India JV. As of May 31, 2025, Loop and Ester had each made total equity contributions of $1.9 million in cash to the India JV. The funds injected in the India JV are being used for preliminary project costs, which are mainly engineering fees.

 

 
8

Table of Contents

 

Subject to the terms of the relevant governing documents, Ester will be the exclusive producer of specialty polymers for the India JV, and Loop will be the exclusive seller and marketing agent of the India JV’s products. Ester and Loop are working in collaboration on all financing activities for the India JV pursuant to the terms of the agreement.

 

The India JV will also enter into (i) a technology license agreement with Loop (the “Loop Technology License Agreement”), (ii) a service agreement with Ester, and (iii) a sales and marketing agreement with Loop, each on terms mutually agreed upon by the parties. Pursuant to the Loop Technology License Agreement, the India JV will be granted an exclusive, subject to certain exceptions, license to exploit the Infinite Loop™ Technology in India at a royalty rate set forth in the Loop Technology License Agreement.

 

Loop has entered into an engineering services agreement with the India JV to provide engineering services and support the local engineering firm. This has resulted in Loop generating engineering services revenue of $0.2 million in the quarter ended May 31, 2025.

 

The development of the Infinite Loop™ India facility continues to progress towards groundbreaking. Following the completion of a detailed land study by an external engineering firm, the India JV partners have identified the Gujarat province of India as the optimal location for the facility based on several key requirements such as infrastructure, proximity to a seaport for exports, renewable energy for a reduction in CO2 emissions and proximity to waste PET and polyester feedstocks. Additionally, feedstock sourcing for the facility, of which there is abundant supply from textile waste in India, is well advanced. Furthermore, ELITe has engaged a leading global advisory firm which has been retained to manage the debt syndication process to finance the construction of the Infinite Loop™ India facility.

 

Based on an engineering study completed by a globally renowned engineering firm in May 2025, the estimated total investment cost for the facility, including continuous polymerization, financing costs during construction and initial working capital requirements, is expected to be approximately $176 million. Groundbreaking for the Infinite Loop™ India facility is now expected to occur in the second half of calendar 2025, with commercial operations projected to commence in calendar 2027.

 

Commercialization Strategy

 

Our commercialization strategy to achieve global expansion of the Infinite Loop™ Technology is founded on a combination of direct investments with strategic partners to own and operate commercial facilities and the licensing of our technology.

 

The global expansion plan for our technology will allow our target customers, mostly comprised of apparel companies and CPG companies, to integrate Loop™ PET resin and polyester fiber into their products and packaging. As countries around the globe continue to impose sustainability targets and recycled content mandates, we observe that companies are increasingly seeking to incorporate sustainably produced materials into their products. Our market strategy is to assist global consumer goods and apparel companies in meeting these requirements as well as their own stated sustainability commitments by offering co-branded packaging or polyester fibers that are made with Loop 100% recycled, virgin-quality PET. We believe that Loop™ recycled PET resin and polyester fiber could command premium pricing over virgin, petroleum-based PET resin and provide attractive economic returns.

 

The Infinite Loop™ Technology is the key pillar of our commercialization strategy. We believe our technology is well positioned to respond to the global transition away from fossil fuels and petrochemicals and into the circular economy, where PET plastic and polyester fiber are produced by recycling waste polyester that would otherwise typically be destined for landfill or incineration, rather than relying on fossil-based resources.

 

We have completed our process design package for the Infinite Loop™ full-scale manufacturing facilities to be used as the base engineering platform for all future facilities. We believe this approach allows for quick execution, speed to market, and lends itself well to modular construction. The basic design package has a capacity of up to 70,000 tons of rDMT and 23,000 tons of rMEG, or 70,000 tons of Loop PET and polyester fiber output per year, subject to applicable site-specific permitting, site and regulatory considerations.

 

 
9

Table of Contents

 

We are focused on direct investments in Infinite Loop™ commercial facilities located in low-cost manufacturing regions. By strategically selecting cost-efficient locations, we aim to optimize production costs and improve overall financial performance, while limiting our capital contributions.

 

This direct investment approach also includes leveraging partnerships to integrate Loop’s proprietary technology and sales and marketing expertise with the operational and construction capabilities of experienced partners. We believe this combination of complementary skill sets allows for more efficient project execution, accelerated market adoption, and scalable growth.

 

We expect that revenue generation from direct investments in commercial facilities will be driven by two key streams: (i) profits from the operation of commercial facilities, and (ii) royalties paid to Loop for licensing its technology and exclusive responsibility of sales and marketing. We believe these income sources will support long-term financial sustainability and growth.

 

This approach is currently being deployed through the Company’s 50/50 joint venture in India with Ester, which is advancing towards the construction of an Infinite Loop™ manufacturing facility. The facility’s planned production capacity is 70,000 tons per year of Loop branded PET resin and polyester fiber. The India JV intends to leverage the complementary skill sets of each partner by combining Loop’s innovative technology and global customer relationships with Ester’s nearly 40 years of specialized polymer production, operational proficiency, and local expertise, including sourcing of PET plastic and polyester fiber waste feedstocks. Loop will grant a royalty-bearing license to the India JV and will be the exclusive seller and marketing agent of the India JV’s products.

 

We also aim to accelerate the roll-out of the Infinite Loop™ technology through the sale of technology licenses for commercial facilities in which Loop may take limited or no ownership. We expect licensee-owned facilities to allow us to scale our technology efficiently, without requiring significant capital investment from Loop. Revenue generation through technology licensing is expected to come from a combination of up-front and recurring royalties.

 

This approach focused on licensing is currently being deployed in our European partnership with Reed Societe Generale Group. The Company sold its first technology license to Reed Societe Generale Group for one Infinite Loop™ manufacturing facility in Europe for an initial down payment of €10.0 million with additional milestone payments to be received by Loop as the project advances. Infinite Loop Europe was formed with the purpose of developing Infinite Loop™ manufacturing facilities in Europe to be owned 10% by Loop and 90% by Reed Societe Generale Group.

 

Additionally, we aim to generate income by providing engineering services throughout all phases of project development, construction, and startup for all Infinite Loop™ commercial facilities, supporting efficient project execution and creating a steady revenue stream prior to the startup of the facility.

 

Loop has entered into an engineering services agreement with the India JV to provide engineering services and support the completion of the engineering for the planned Infinite Loop™ manufacturing facility in India. This has resulted in Loop generating engineering services revenue of $0.2 million in the quarter ended May 31, 2025.

 

We are also in the process of implementing a modular construction strategy, in order to reduce overall capital expenditures and operating expenses, while improving project timelines and ensuring standardized design and quality, and providing a scalable solution for global expansion. This strategy envisages that we would manufacture plant modules in a low-cost country to be transported and assembled on site at global locations, and would potentially provide an additional income stream alongside returns from owned facilities and royalties.

 

The Company’s ability to move to the next stage of its strategic development, including the construction of manufacturing plants and the commercialization of its technology and products at scale, is dependent on, among other factors, its ability to obtain the necessary financing through a combination of the issuance of equity, project debt, and/or government incentive programs.

 

Recent Development – ATM Offering

 

On July 3, 2025, we entered into an At the Market Offering Agreement (the “Sales Agreement”) with Roth Capital Partners, LLC (“Sales Agent”), under which we may offer and sell shares of our common stock having an aggregate offering price of up to $15 million from time to time through or to the Sales Agent, acting as our sales agent or principal (the “ATM”). We are not obligated to make any sales of shares under the Sales Agreement and we may not sell any shares under the Sales Agreement, or if we do, as to the price or amount of shares that we will sell, or the date on which any such sales will take place.

 

Human Capital

 

As of May 31, 2025, we had 44 employees of which 18 work in research and development, 17 in engineering and operations, and 9 in administrative functions.

 

 
10

Table of Contents

 

Results of Operations

 

All monetary amounts are in thousands of U.S. dollars unless otherwise specified.

 

The following table summarizes our operating results for the three-month periods ended May 31, 2025 and 2024, in thousands of U.S. Dollars.

 

 

 

Three months ended May 31,

 

 

 

2025

 

 

2024

 

 

Change

favorable / (unfavorable)

 

Revenues

 

$252

 

 

$6

 

 

$246

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Expenses

 

 

 

 

 

 

 

 

 

 

 

 

Research and development

 

 

 

 

 

 

 

 

 

 

 

 

Employee compensation

 

 

702

 

 

 

1,015

 

 

 

313

 

Stock-based compensation

 

 

312

 

 

 

129

 

 

 

(183)

External engineering

 

 

5

 

 

 

628

 

 

 

623

 

Plant and laboratory operating expenses

 

 

231

 

 

 

270

 

 

 

39

 

Other

 

 

124

 

 

 

195

 

 

 

71

 

Total research and development

 

 

1,374

 

 

 

2,237

 

 

 

863

 

 

 

 

 

 

 

 

 

 

 

 

 

 

General and administrative

 

 

 

 

 

 

 

 

 

 

 

 

Employee compensation

 

 

569

 

 

 

635

 

 

 

66

 

Stock-based compensation

 

 

63

 

 

 

241

 

 

 

178

 

Professional fees

 

 

361

 

 

 

1,255

 

 

 

894

 

Insurance

 

 

453

 

 

 

492

 

 

 

39

 

Other

 

 

203

 

 

 

288

 

 

 

85

 

Total general and administrative

 

 

1,649

 

 

 

2,911

 

 

 

1,262

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Loss on equity accounted investment

 

 

302

 

 

 

-

 

 

 

(302)

Depreciation and amortization

 

 

100

 

 

 

137

 

 

 

37

 

Interest and other financial expenses (income)

 

 

419

 

 

 

60

 

 

 

(359)

Interest income

 

 

(100)

 

 

(126)

 

 

(26)

Foreign exchange gain

 

 

(45)

 

 

(24)

 

 

21

 

Total expenses

 

 

3,699

 

 

 

5,195

 

 

 

1,496

 

Net loss

 

$(3,447)

 

$(5,189)

 

$1,742

 

 

First Quarter Ended May 31, 2025

 

Revenues

 

Revenues for the three-month period ended May 31, 2025 increased $246 to $252, as compared to $6 for the same period in 2024. The revenues for the three-month period ended May 31, 2025 resulted from $244 in engineering fees and $8 from sales of Loop PET resin produced using monomers manufactured at the Terrebonne Facility. The revenues of $6 for the three-month period ended May 31, 2024 resulted from sales of Loop PET resin.

 

Research and Development

 

Research and development expense for the three-month period ended May 31, 2025 decreased $863 to $1,374, as compared to $2,237 for the same period in 2024. The decrease was primarily attributable to a $623 decrease in external engineering expenses for design work for our Infinite Loop™ manufacturing process, and a $313 decrease in employee compensation expenses, partially offset by a $183 increase in stock-based compensation expenses.

 

 
11

Table of Contents

 

General and administrative expenses

 

General and administrative expenses for the three-month period ended May 31, 2025 decreased $1,262 to $1,649, as compared to $2,911 for the same period in 2024. The decrease was primarily attributable to a $894 decrease in professional fees, which was mainly attributable to legal costs related to our partnerships with Reed Societe Generale Group and Ester incurred in the three-month period ended May 31, 2024, a $178 decrease in stock-based compensation expense mainly due to $(268) of forfeitures recorded in the three-month period ended May 31, 2025, and a decrease of $66 in employee compensation expenses.

 

Loss on equity accounted investment

 

Loss on equity accounted investment increased by $302 for the three-month period ended May 31, 2025. This loss relates to the Company’s 50% portion of the loss incurred by the India JV for the three-month period ended May 31, 2025, during which the India JV incurred preliminary project costs for the planned Infinite Loop™ facility in India, which are mainly engineering fees.

 

Interest and other financial expenses

 

Interest and other financial expenses increased by $359 for the three-month period ended May 31, 2025. This increase is mainly attributable to the accrued PIK dividend on the Series B Convertible Preferred Stock issued to RCE recorded as an interest expense for $340 in the three-month period ended May 31, 2025 (2024 – nil).

 

Net Loss

 

The net loss for the three-month period ended May 31, 2025 decreased $1,742 to $3,447, as compared to $5,189 for the same period in 2024. This decrease was primarily due to the decrease of $1,262 in general and administrative expenses and the decrease of $863 in research and development expenses, which were partially offset by the $359 increase in interest and other financial expenses and the increase of $302 in loss on equity accounted investment.

  

LIQUIDITY AND CAPITAL RESOURCES

 

All monetary amounts are in thousands of U.S. dollars unless otherwise specified.

 

Since its inception, the Company has been in the pre-commercialization stage with its ongoing operations and commercialization plans financed primarily by raising equity. The Company has incurred net losses and negative cash flow from operating and investing activities since its inception and expects to incur additional net losses while it continues to advance its commercialization efforts. As at May 31, 2025, the Company had cash and cash equivalents of $9,748. Our liquidity position is subject to risks and uncertainties, including those discussed under “Cautionary Statements Regarding Forward-Looking Statements” in this Quarterly Report on Form 10-Q and the Risk Factors section included in Part I, Item 1A of our 2025 Annual Report.

 

Management continuously monitors the Company’s cash resources against its short-term cash commitments to ensure there is sufficient liquidity to fund its costs for at least twelve months from the financial statements issuance date. It evaluates the Company’s liquidity to determine if there is substantial doubt about its ability to continue as a going concern. In preparing this liquidity assessment, management applies significant judgment in estimating future cash flow requirements of the Company based on budgets and forecasts, which includes developing assumptions related to: (i) the estimation of amount and timing of future cash outflows and inflows, and (ii) determining what future expenditures are committed and what could be considered discretionary. Based on this assessment, management believes that current available liquidity will be sufficient to meet the Company’s obligations, commitments and budgeted expenditures for at least twelve months from the issuance date of the unaudited interim condensed consolidated financial statements.

 

 
12

Table of Contents

 

The Company’s ability to move to the next stage of its strategic development and construct manufacturing facilities is dependent on, among other factors, whether the Company can obtain the necessary financing through a combination of further technology licensing arrangements, government incentive programs, and/or the issuance of debt and/or equity. In particular, the Company will require capital sufficient to fund its equity contributions to the India JV for the construction of the planned Infinite Loop™ facility in India, as well as its ongoing cash requirements. The Company’s financing requirements may potentially be reduced depending on the timing of anticipated revenues from engineering services for the European partnership with Reed Societe Generale Group.

 

There is no assurance that the Company will be successful in attracting additional funding. Even if additional financing is available, it may not be available on terms favorable to the Company. Failure to secure additional financing on favorable terms when it becomes required would have an adverse effect on the Company’s financial position and on its ability to execute its business plan.

 

Sale and issuance of Series B CPS

 

On December 23, 2024 (the “Issuance Date”), the Company issued and sold 1,044,430 shares of Series B CPS at $10.00 per share to Reed Circular Economy (the “Holder”), an affiliate of Reed Societe Generale Group, for cash proceeds of $10,395 (€10,000). The main features of the Series B CPS are as follows:

 

 

·

Automatic conversion of the stated value ($10,395 on the Issuance Date) on the fifth anniversary of the Issuance Date into shares of the Company’s common stock at a conversion price of $4.75 per share;

 

·

Accrues a cumulative fixed annual PIK dividend at a rate of 13% of the stated value, which is added to the stated value of the Series B CPS on September 30 of each year;

 

·

Redeemable in cash at any time, starting after the third anniversary of the Issuance Date by the Company (issuer call option);

 

·

Redeemable in cash on the fifth anniversary of the Issuance Date at the option of the Holder (put feature); and

 

·

Voting rights equal to the number of whole shares of the Company’s common stock (rounded to the nearest whole share) into which the stated value of Series B CPS would be convertible on a given date; and separate class voting rights on certain matters such as amendments to the Certificate of Designation or Articles of Incorporation that adversely affect the rights of the Series B CPS, as long as at least 50,000 shares of Series B CPS are outstanding.

 

The foregoing summary does not purport to be complete and is qualified in its entirety by reference to the full text of the Certificate of Designation, which was filed as Exhibit 3.1 to our Current Report on Form 8-K filed with the SEC on December 26, 2025.

 

Investissement Québec financing facility

 

We have a long-term debt obligation to Investissement Québec in connection with a financing facility (the “Financing Facility”) for the expansion of the Terrebonne Facility up to a maximum of $3,344. We received the first disbursement in the amount of $1,606 on February 21, 2020 and the second disbursement in the amount of $1,738 on August 26, 2021. The loan can be repaid at any time by us without penalty. The loan’s interest rate was initially set at 2.36% and there was a 36-month moratorium on both capital and interest repayments as of the first disbursement date. Under the original terms of the Financing Facility, at the end of the 36-month moratorium, capital and interest was repayable in 84 monthly installments. There is no remaining amount available under the Financing Facility after the second disbursement.

 

On November 21, 2022, the Company and Investissement Québec entered into an agreement to amend the existing Financing Facility which modifies the repayments of the principal amount (the “Financing Facility Amendment”). As per the Financing Facility Amendment, a total of $36 of the principal amount was repayable in monthly installments in the fiscal year ended February 29, 2024, with the remainder of the principal amount being repayable in 72 monthly installments.

 

On February 28, 2024, the Company and Investissement Québec entered into an agreement to amend the existing Financing Facility which modifies the repayments of the principal amount (the “Second Financing Facility Amendment”). As per the Second Financing Facility Amendment, a total of $73 of the principal amount was repayable in monthly installments in the fiscal year ended February 28, 2025, with the remainder of the principal amount being repayable in 60 monthly installments. Pursuant to the Second Financing Facility Amendment the interest rate of the Financing Facility was increased from 2.36% to 3.36%.

 

 
13

Table of Contents

 

On February 5, 2025, the Company and Investissement Québec entered into an agreement to amend the existing Financing Facility which modifies the repayments of the principal amount (the “Third Financing Facility Amendment”). As per the Third Financing Facility Amendment, total annual principal repayments in monthly installments are of $301 for the fiscal year ending February 28, 2026 and $519 for the fiscal year ending February 28, 2027, with the remainder of the principal amount being repayable in 36 monthly installments. Pursuant to the Third Financing Facility Amendment the interest rate of the Financing Facility was increased from 3.36% to 4.36%.

 

Under the original terms of the Financing Facility, the principal amount was repayable in 84 monthly installments beginning in March of 2023. The amendments do not modify the repayment terms of accrued interest or any of the other terms of the Financing Facility that are not mentioned above. The amendments did not meet the criteria of ASC 470, Debt for an extinguishment of debt as the amendments did not substantially modify the terms of the Financing Facility. The Company therefore applied modification accounting and no immediate gain or loss was recognized related to the amendments.

 

Credit facility from a Canadian bank

 

On July 26, 2022, Loop Canada, Inc., a wholly-owned subsidiary of the Company, entered into an Operating Credit Facility (the “Credit Facility”) with a Canadian bank. The Credit Facility allows for borrowings of up to $2,544 in aggregate principal amount. The Credit Facility is secured by the Company’s Terrebonne, Québec property and is subject to a minimum equity covenant, tested quarterly with which the Company was not in compliance as at May 31, 2025. All borrowings under the Credit Facility will bear interest at an annual rate equal to the bank’s Canadian prime rate plus 1.0%. As at May 31, 2025, the $2,544 Credit Facility was available and undrawn.

 

On July 4, 2025, the Company and the Canadian Bank executed an amendment to the Credit Facility, modifying the minimum equity covenant to include the balance of Series B Convertible Preferred Stock as at February 28, 2025 of $10,647 in the calculation of stockholders’ equity. The Company was in compliance with the minimum equity covenant following this amendment.

 

Flow of Funds

 

All monetary amounts are in thousands of U.S. dollars unless otherwise specified.

 

Summary of Cash Flows

 

A summary of cash flows for the three months ended May 31, 2025 and 2024 was as follows, in thousands of U.S. Dollars:

 

 

 

Three Months Ended May 31,

 

 

 

2025

 

 

2024

 

Net cash used in operating activities

 

$(3,082)

 

$(3,915)

Net cash used in investing activities

 

 

(115)

 

 

(176)

Net cash provided by (used in) financing activities

 

 

(55)

 

 

2,492

 

Effect of exchange rate changes on cash

 

 

27

 

 

 

(68)

Net decrease in cash

 

$(3,225)

 

$(1,667)

 

Net Cash Used in Operating Activities

 

During the three-month period ended May 31, 2025, we used $3,082 in operations compared to $3,915 during the three-month period ended May 31, 2024. As discussed above in the Results of Operations, the year-over-year decrease is mainly due to decreased operating expenses as we have completed the upgrade of the Terrebonne Facility and our basic design package for the Infinite Loop full-scale manufacturing facilities, and lower legal costs related to forming our partnerships with Reed Societe Generale Group and Ester.

 

Net Cash Used in Investing Activities

 

During the three months ended May 31, 2025, we used $115 in investing activities compared to $176 during the three-month period ended May 31, 2024. During the three months ended May 31, 2025, we made investments in intangible assets of $115, particularly to file patents for the Infinite Loop™ technology in the United States and around the world. During the three months ended May 31, 2024, we made investments in intangible assets of $176.

  

Net Cash Provided by (Used in) Financing Activities

 

During the three months ended May 31, 2025, we repaid $55 of long-term debt. During the three months ended May 31, 2024, we borrowed $2,517 under the Credit Facility and we repaid $25 of long-term debt.

 

 
14

Table of Contents

 

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

Pursuant to Item 305(e) of Regulation S-K (§ 229.305(e)), the Company is not required to provide the information required by this Item as it is a “smaller reporting company,” as defined by Rule 229.10(f)(1).

 

ITEM 4. CONTROLS AND PROCEDURES

 

Management’s Evaluation of our Disclosure Controls and Procedures

 

A. Evaluation of Disclosure Controls and Procedures

 

Disclosure controls and procedures are designed to provide reasonable assurance that information required to be disclosed by us in the reports that we file or submit under the Securities Exchange Act of 1934, is recorded, processed, summarized and reported, within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by us in our reports that we file or submit under the Securities Exchange Act of 1934 is accumulated and communicated to our management, including our principal executive and principal financial officers, or persons performing similar functions, as appropriate, to allow timely decisions regarding required disclosure.

 

As of the end of the period covered by this Quarterly Report, the Company carried out an evaluation, under the supervision and with the participation of the Company’s management, including the Company’s Chief Executive Officer and Interim Chief Financial Officer, of the effectiveness of the design and operation of the Company’s “disclosure controls and procedures” (as defined in Rule 13a-15(e) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), pursuant to Rule 13a-15(b) of the Exchange Act. Based upon that evaluation, the Chief Executive Officer and Interim Chief Financial Officer concluded that the Company’s disclosure controls and procedures were effective as of May 31, 2025.

 

B. Changes in Internal Control over Financial Reporting

 

There were no changes in our internal control over financial reporting during the quarter ended May 31, 2025 that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

 
15

Table of Contents

 

PART II. OTHER INFORMATION

 

ITEM 1. LEGAL PROCEEDINGS

 

SEC Investigation

 

As previously disclosed, we received a subpoena from the SEC in October 2020 requesting certain information from us, including information regarding testing, testing results and details of results from our GEN I and GEN II technologies, and certain of our partnerships and agreements. In March 2022, we received a second subpoena requesting additional information, including information concerning our reverse-merger in 2015, and communications with certain individuals and entities. There have been no additional information requests from the SEC relating to the Company’s business or technology.

 

The SEC informed us that its investigation does not mean that the SEC has concluded that anyone has violated the law and that the investigation does not mean that the SEC has a negative opinion of us. We cannot predict when this matter will be resolved or what, if any, action the SEC may take following the conclusion of the investigation.

 

On September 30, 2022, the SEC filed a complaint (the “SEC complaint”) against several named defendants (“Defendants”), and also identified as a relief defendant Daniel Solomita, our Chief Executive Officer. The SEC complaint does not allege wrongdoing by the Company or Mr. Solomita. The SEC complaint identifies Mr. Solomita and an entity he owns as relief defendants because they purportedly received monies from the Defendants in 2015 that the SEC alleges were derived from the Defendants’ fraud. The SEC complaint does not allege that Mr. Solomita was aware of the alleged wrongdoing by the Defendants and does not allege that he was aware that any alleged monies received were derived from fraud.

 

Litigation

 

From time to time, we may become involved in various lawsuits and legal proceedings or investigations which arise in the ordinary course of business. Except as noted above, we are not presently a party to any legal proceedings, government actions, administrative actions, investigations or claims that are pending against us or involve us that, in the opinion of our management, could reasonably be expected to have a material adverse effect on our business, financial condition or operating results. However, litigation is subject to inherent uncertainties, and an adverse result in these or other matters may arise from time to time that may harm our business.

 

It is possible that we may expend financial and managerial resources in the defense of our intellectual property rights in the future if we believe that our rights have been violated. It is also possible that we may expend financial and managerial resources to defend against claims that our products and services infringe upon the intellectual property rights of third parties.

 

 
16

Table of Contents

 

ITEM 1A. RISK FACTORS

 

We are subject to various risks and uncertainties in the course of our business.  Risk factors relating to us are set forth under “Risk Factors” in our 2025 Annual Report. No material changes to such risk factors have occurred during the three months ended May 31, 2025. An additional risk factor is included below in connection with the recent launch of our ATM offering.

 

The sale or issuance of our common stock in an at-the-market offering, pursuant to an At the Market Offering Agreement (“Sales Agreement”) with Roth Capital Partners, LLC, may cause dilution and the sale of the shares of common stock sold pursuant to the Sales Agreement, or the perception that such sales may occur, could cause the price of our common stock to fall.

 

On July 3, 2025, we entered into an At the Market Offering Agreement with Roth Capital Partners, LLC (“Sales Agent”), under which we may offer and sell shares of our common stock having an aggregate offering price of up to $15 million from time to time through or to the Sales Agent, acting as our sales agent or principal

 

Under the Sales Agreement, we will set the parameters for the sale of shares, including the number of shares to be issued, the time period during which sales are requested to be made, limitation on the number of shares that may be sold in any one trading day and any minimum price below which sales may not be made. Subject to the terms and conditions of the Sales Agreement, the Sales Agent may sell the shares by methods deemed to be an “at-the-market” offering as defined in Rule 415 promulgated under the Securities Act, including sales made directly on or through The Nasdaq Global Market, the existing trading market for the Company’s common stock, sales made to or through a market maker other than on an exchange or otherwise, directly to the Sales Agent as principal, in negotiated transactions at market prices prevailing at the time of sale or at prices related to such prevailing market prices, and/or in any other method permitted by law. The Sales Agreement provides that the Sales Agent will be entitled to compensation for its services in an amount equal to 3.0% of the gross proceeds from the sale of shares sold under the Sales Agreement.

 

Depending on market liquidity at the time, sales of shares under the Sales Agreement may cause the trading price of our common stock to fall. Additionally, further sales of our common stock, if any, under the Sales Agreement will depend upon market conditions and other factors to be determined by us. We ultimately may sell all, some or none of the shares of our common stock that may be sold pursuant to the Sales Agreement and, after such shares have been sold, the purchasers may sell all, some or none of those shares. Therefore, sales under the Sales Agreement could result in substantial dilution to the interests of other holders of our common stock. Additionally, the sale of a substantial number of shares of our common stock under the Sales Agreement, or the anticipation of such sales, could make it more difficult for us to sell equity or equity-related securities in the future at a time and at a price that we might otherwise wish to effect such sales. 

 

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

 

None.

 

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

 

None.

 

ITEM 4. MINE SAFETY DISCLOSURES

 

Not applicable.

 

ITEM 5. OTHER INFORMATION

 

During the three months ended May 31, 2025, no director or officer of the Company adopted or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408 of Regulation S-K.

 

 
17

Table of Contents

 

ITEM 6. EXHIBITS

 

The following Exhibits, as required by Item 601 of Regulation SK, are attached or incorporated by reference, as stated below.

 

Exhibit Index

 

Incorporated by Reference

Number

Description

Form

File No.

Filing Date

Exhibit No.

3.1

Articles of Incorporation, as amended to date

10-K

001-38301

May 29, 2024

3.1

3.2

 

Certificate of Designation of Preferences, Rights and Limitations of Series B Convertible Preferred Stock.

 

8-K

 

001-38301

 

December 26, 2024

 

3.1

3.3

By-laws, as amended to date

8-K

001-38301

April 10, 2018

3.1

31.1

Certification of Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

Filed herewith

31.2

Certification of Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

 

 

 

Filed herewith

 

 

 

 

32.1

Certification of Principal Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

Furnished herewith

32.2

Certification of Principal Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

 

 

 

Furnished herewith

 

 

 

 

101.INS

XBRL Instance Document

Filed herewith

101.SCH

XBRL Taxonomy Extension Schema Document

 

 

 

Filed herewith

 

 

 

 

101.CAL

XBRL Taxonomy Extension Calculation Linkbase Document

Filed herewith

101.DEF

XBRL Taxonomy Extension Definition Linkbase Document

 

 

 

Filed herewith

 

 

 

 

101.LAB

XBRL Taxonomy Extension Label Linkbase Document

Filed herewith

101.PRE

XBRL Taxonomy Extension Presentation Linkbase Document

 

 

 

Filed herewith

 

 

 

 

104

 

Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

 

 

 

Filed herewith

 

 

 

 

 

 
18

Table of Contents

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

Date: July 15, 2025

By:

/s/ Daniel Solomita

 

 

Name:

Daniel Solomita

 

 

Title:

President and Chief Executive Officer, and Director (Principal Executive Officer)

 

 

 

 

 

Date: July 15, 2025

By:

/s/ Nicolas Lafond

Name:

Nicolas Lafond

Title:

Interim Chief Financial Officer (Principal Accounting Officer and Principal Financial Officer)

 

 
19

 

FAQ

How many Milestone Pharmaceuticals (MIST) shares did the CEO buy?

Joseph Oliveto purchased 66,666 common shares on 11 July 2025.

What is included in each Unit purchased by the MIST CEO?

Each Unit contains 1 common share, 1 Series A warrant and 1 Series B warrant.

What are the exercise terms of the Series A warrants?

Series A warrants are fully vested, exercise price $1.50, and expire on 11 July 2026.

When do the Series B warrants held by the CEO expire?

Series B warrants expire on 11 July 2030 and have an exercise price of $1.875.

How many MIST shares does the CEO own after this transaction?

Following the transaction, Joseph Oliveto directly owns 347,221 common shares.

Does the Form 4 indicate any share sales by the CEO?

No. The filing only reports acquisitions (code A); there are no dispositions.
Loop Industries

NASDAQ:LOOP

LOOP Rankings

LOOP Latest News

LOOP Latest SEC Filings

LOOP Stock Data

53.44M
22.11M
51.01%
14.99%
1.61%
Specialty Chemicals
Chemicals & Allied Products
Link
Canada
TERREBONNE